COLIBRI RESOURCES CORP (CBI.CA) Fundamental Analysis & Valuation

TSX-V:CBI • CA1941684070

Current stock price

0.115 CAD
+0.01 (+4.55%)
Last:

This CBI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CBI.CA Profitability Analysis

1.1 Basic Checks

  • CBI had negative earnings in the past year.
  • CBI had a negative operating cash flow in the past year.
  • In multiple years CBI reported negative net income over the last 5 years.
  • In the past 5 years CBI always reported negative operating cash flow.
CBI.CA Yearly Net Income VS EBIT VS OCF VS FCFCBI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M

1.2 Ratios

Industry RankSector Rank
ROA -20.34%
ROE -39.99%
ROIC N/A
ROA(3y)-17.1%
ROA(5y)-9.34%
ROE(3y)-28.4%
ROE(5y)-15.33%
ROIC(3y)N/A
ROIC(5y)N/A
CBI.CA Yearly ROA, ROE, ROICCBI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for CBI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CBI.CA Yearly Profit, Operating, Gross MarginsCBI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. CBI.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CBI has been increased compared to 1 year ago.
  • Compared to 5 years ago, CBI has more shares outstanding
  • CBI has a worse debt/assets ratio than last year.
CBI.CA Yearly Shares OutstandingCBI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CBI.CA Yearly Total Debt VS Total AssetsCBI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • CBI has an Altman-Z score of -5.16. This is a bad value and indicates that CBI is not financially healthy and even has some risk of bankruptcy.
  • A Debt/Equity ratio of 0.25 indicates that CBI is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -5.16
ROIC/WACCN/A
WACCN/A
CBI.CA Yearly LT Debt VS Equity VS FCFCBI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

2.3 Liquidity

  • CBI has a Current Ratio of 0.06. This is a bad value and indicates that CBI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CBI has a Quick Ratio of 0.06. This is a bad value and indicates that CBI is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
CBI.CA Yearly Current Assets VS Current LiabilitesCBI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CBI.CA Growth Analysis

3.1 Past

  • The earnings per share for CBI have decreased strongly by -19.89% in the last year.
EPS 1Y (TTM)-19.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. CBI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CBI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBI.CA Price Earnings VS Forward Price EarningsCBI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBI.CA Per share dataCBI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBI.CA Dividend Analysis

5.1 Amount

  • No dividends for CBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CBI.CA Fundamentals: All Metrics, Ratios and Statistics

COLIBRI RESOURCES CORP

TSX-V:CBI (3/25/2026, 7:00:00 PM)

0.115

+0.01 (+4.55%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)12-01
Earnings (Next)04-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners7.43%
Ins Owner ChangeN/A
Market Cap4.24M
Revenue(TTM)N/A
Net Income(TTM)-950.90K
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.78
P/tB 1.78
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.34%
ROE -39.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.1%
ROA(5y)-9.34%
ROE(3y)-28.4%
ROE(5y)-15.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 104.79%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -5.16
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)890.59%
Cap/Depr(5y)1082.39%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-19.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y41.05%
OCF growth 3YN/A
OCF growth 5YN/A

COLIBRI RESOURCES CORP / CBI.CA Fundamental Analysis FAQ

What is the fundamental rating for CBI stock?

ChartMill assigns a fundamental rating of 0 / 10 to CBI.CA.


Can you provide the valuation status for COLIBRI RESOURCES CORP?

ChartMill assigns a valuation rating of 0 / 10 to COLIBRI RESOURCES CORP (CBI.CA). This can be considered as Overvalued.


How profitable is COLIBRI RESOURCES CORP (CBI.CA) stock?

COLIBRI RESOURCES CORP (CBI.CA) has a profitability rating of 0 / 10.